Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potential future therapies: natriuretic peptides.

O Lisy1, J C Burnett

  • 1Department of Physiology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA. Lisy.Ondrej2@mayo.edu

Coronary Artery Disease
|September 4, 1999
PubMed
Summary

Natriuretic peptides help manage heart failure by regulating fluid balance and blood pressure. They are also useful for diagnosing early ventricular dysfunction, offering new strategies to delay heart failure progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the Use of Chloral Hydrate in Lethargic Somnolency.

The Homoeopathic physician·2023
Same author

Insulin/glucose induces natriuretic peptide clearance receptor in human adipocytes: a metabolic link with the cardiac natriuretic pathway.

American journal of physiology. Regulatory, integrative and comparative physiology·2016
Same author

PTH: Potential role in management of heart failure.

Clinica chimica acta; international journal of clinical chemistry·2014
Same author

Pharmacophore-guided lead optimization: the rational design of a non-zinc coordinating, sub-micromolar inhibitor of the botulinum neurotoxin serotype a metalloprotease.

Bioorganic & medicinal chemistry letters·2009
Same author

Stem cells, ribozymes and HIV.

Gene therapy·2009
Same author

Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study.

Heart (British Cardiac Society)·2009

Area of Science:

  • Cardiology
  • Nephrology
  • Endocrinology

Background:

  • Congestive heart failure (CHF) is a significant public health issue.
  • Neurohumoral activation, marked by elevated natriuretic peptides like atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), is a key feature of CHF.
  • The natriuretic peptide system is crucial for cardiorenal regulation, controlling intravascular volume and arterial pressure.

Purpose of the Study:

  • To explore the diagnostic and therapeutic applications of natriuretic peptides in managing heart failure.
  • To highlight the role of natriuretic peptides in early detection of left ventricular dysfunction.
  • To present natriuretic peptides as a novel strategy to alter the course of heart failure.

Main Methods:

  • Review of existing literature on neurohumoral activation in heart failure.

Related Experiment Videos

  • Analysis of the diagnostic utility of natriuretic peptides (ANP and BNP) for asymptomatic left ventricular dysfunction.
  • Evaluation of therapeutic strategies that mimic or enhance natriuretic peptide actions.

    • Main Results:

    • Elevated natriuretic peptides indicate ventricular dysfunction in heart failure.
    • Natriuretic peptides play a vital role in maintaining circulatory integrity through cardiorenal regulation.
    • Therapeutic interventions targeting the natriuretic peptide system show promise.

    Conclusions:

    • Natriuretic peptides have established diagnostic value for early asymptomatic left ventricular dysfunction.
    • Therapeutic approaches leveraging natriuretic peptides offer a new strategy to manage heart failure.
    • The combined diagnostic and therapeutic use of natriuretic peptides can potentially delay the progression of heart failure.